If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
124.50    1.50 (1.22%)
Bid:
117.50
Ask:
125.00
Spread: 7.50 (6.383%)
Market Cap: £97.70m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Year End Trading Update

20 Jan 2011 07:00

RNS Number : 7772Z
Xaar PLC
20 January 2011
 



 

FOR IMMEDIATE RELEASE

20 January 2011

 

 

Xaar plc

 

YEAR END TRADING UPDATE

 

Xaar plc ("the Group"), the inkjet printing technology group headquartered in Cambridge, announces an update on trading performance for the year ended 31 December 2010.

 

Trading

 

Trading for the three months ended 31 December 2010, and for the year as a whole, is significantly ahead of trading for the same periods last year.

 

Sales of Platform 3 ("P3") products have been substantially ahead of 2009 and, as previously reported, are currently constrained by production capacity. The recent Placing and Open Offer, completed in November, raised £14.0 million (net) to fund a substantial increase in P3 production. This production capacity expansion programme is now underway, with the first increases to output planned before the end of 2011. The programme is currently on schedule, and is expected to complete before the end of 2012.

 

Sales of Platform 1 products have remained at 2009 levels whilst royalty income has increased over last year.

 

As a result of the continued strong performance in the three months ended 31 December 2010, overall profitability for the year is expected to be slightly ahead of directors' expectations.

 

Cash

 

The Group continues to maintain a strong balance sheet with net cash at 31 December 2010 of £22.0 million (30 June 2010 - £8.2 million; 31 December 2009 - £11.1 million) including the £14.0m net proceeds from the Placing and Open Offer.

 

Dividend

 

It is the Board's intention to recommend the payment of a final dividend, details of which will be provided at the time of the announcement of the final results for the year.

 

Announcement of final results

 

The detailed results for 2010 will be announced, in accordance with Xaar's normal timetable, on 22 March 2011.

 

Investor site visit

 

The Group will be hosting a visit for institutional investors at its Huntingdon manufacturing facility on Friday 21st January. No new information will be disclosed during the visit.

 

END

 

 

CONTACTS

 

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Andrew Taylor, Finance Director

Singer Capital Markets Limited:

020-3205-7500

Shaun Dobson

Bankside Consultants:

Simon Bloomfield

020-7367-8888 / 07771-758517

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUKUWRAWAAAAR
Date   Source Headline
26th Apr 20215:51 pmRNSHolding(s) in Company
22nd Apr 202112:18 pmRNSDirector Declaration
15th Apr 20212:24 pmRNSNotice of 2020 Preliminary Results
6th Apr 202112:12 pmRNSHolding(s) in Company
1st Apr 20211:50 pmRNSTotal Voting Rights
1st Mar 20215:18 pmRNSTotal Voting Rights
10th Feb 20212:25 pmRNSHolding(s) in Company
1st Feb 202111:01 amRNSTotal Voting Rights
28th Jan 20212:49 pmRNSHolding(s) in Company
21st Jan 202110:27 amRNSHolding(s) in Company
14th Jan 20217:00 amRNSTrading Statement
4th Jan 202111:38 amRNSTotal Voting Rights
1st Dec 20204:43 pmRNSTotal Voting Rights
9th Nov 202010:42 amRNSHolding(s) in Company
4th Nov 202011:00 amRNSUpdate on cyber security incident
3rd Nov 202011:29 amRNSGrant of options under SAYE Scheme
3rd Nov 202011:15 amRNSHolding(s) in Company
2nd Nov 202011:40 amRNSTotal Voting Rights
7th Oct 20207:00 amRNSNotice of cyber security incident
6th Oct 20204:48 pmRNSHolding(s) in Company
1st Oct 202012:59 pmRNSTotal Voting Rights
30th Sep 20207:00 amRNS2020 Interim Results
3rd Sep 20204:24 pmRNSHolding(s) in Company
3rd Sep 20201:20 pmRNSNotice of Interim Results
1st Sep 202010:42 amRNSTotal Voting Rights
5th Aug 202012:47 pmRNSTotal Voting Rights
3rd Aug 20208:59 amRNSChange of Adviser
16th Jul 20207:00 amRNSTrading Statement
9th Jul 20204:36 pmRNSPrice Monitoring Extension
1st Jul 20203:17 pmRNSConfirmation of Board Change & Succession
1st Jul 202011:47 amRNSTotal Voting Rights
5th Jun 20207:00 amRNSGrant of Options
2nd Jun 202011:16 amRNSTotal Voting Rights
2nd Jun 202011:13 amRNSResult of AGM
2nd Jun 20207:00 amRNSTrading Statement
15th May 202010:59 amRNSHolding(s) in Company
7th May 20207:00 amRNSNotice of Annual General Meeting
1st May 20203:10 pmRNSTotal Voting Rights
30th Apr 20202:27 pmRNSHolding(s) in Company
29th Apr 202012:04 pmRNSDisclosure of Rights attached to Equity Shares
29th Apr 202011:41 amRNSGrant of option
28th Apr 20205:27 pmRNSHolding(s) in Company
27th Apr 20202:23 pmRNSHolding(s) in Company
27th Apr 20202:00 pmRNSDirectorate Change - Appointment
24th Apr 20203:10 pmRNSHolding(s) in Company
24th Apr 20203:02 pmRNSAnnual Financial Report
23rd Apr 20202:35 pmRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNSAnnual Financial Report
9th Apr 20209:15 amRNSHolding(s) in Company
6th Apr 20203:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.